Degarelix clinical trials: 63 trials
Page 1 of 2
Read 63 Degarelix clinical trials with posted results or linked papers with results in PepBank.
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00936390 · Phase 3 · Completed
Posted results
- A Trial of Degarelix in Patients With Prostate Cancer
NCT00946920 · Phase 3 · Completed
Posted results
- The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
NCT00295750 · Phase 3 · Completed
Posted results
- A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
NCT02663908 · Phase 3 · Terminated
Posted results
- A Study of Degarelix in Patients With Prostate Cancer
NCT00928434 · Phase 3 · Completed
Posted results
- A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
NCT00451958 · Phase 3 · Completed
Posted results
- A Degarelix Trial in Patients With Prostate Cancer
NCT01242748 · Phase 3 · Terminated
Posted results
- Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
NCT00268892 · Phase 2/3 · Completed
Posted results
- Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
NCT00833248 · Phase 3 · Completed
Posted results
- Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer
NCT00801242 · Phase 3 · Completed
Posted results
- Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients
NCT00884273 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer
NCT01071915 · Phase 3 · Completed
Posted results
- An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer
NCT00215683 · Phase 2/3 · Completed
Posted results
- Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients
NCT01215513 · Phase 3 · Completed
Posted results
- A Study of Degarelix in Taiwanese Patients With Prostate Cancer
NCT01220869 · Phase 3 · Completed
Posted results
- A Long Term Safety Study of Degarelix in Patients With Prostate Cancer
NCT00967018 · Phase 3 · Completed
Posted results
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
NCT00117286 · Phase 2/3 · Completed
Posted results
- Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
NCT03056638 · Phase 3 · Terminated
Posted results
- Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer
NCT00831233 · Phase 3 · Terminated
Posted results
- A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer
NCT01964170 · Phase 3 · Completed
Linked paper with results
- Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
NCT01709942 · Phase 3 · Completed
Linked paper with results
- Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix
NCT03202381 · Phase 4 · Status unknown
Linked paper with results
- A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
NCT00116753 · Phase 2 · Completed
Posted results
- A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
NCT00947882 · Phase 2 · Completed
Posted results
- Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer
NCT00819156 · Phase 2 · Completed
Posted results
- Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients
NCT00818623 · Phase 2 · Completed
Posted results
- Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
NCT00468286 · Phase 2 · Completed
Posted results
- Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients
NCT00215657 · Phase 2 · Terminated
Posted results
- The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer
NCT00819247 · Phase 2 · Completed
Posted results
- A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
NCT00116779 · Phase 2 · Completed
Posted results
- 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT01751451 · Phase 2 · Completed
Posted results
- Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer
NCT02135445 · Phase 2 · Completed
Posted results
- Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
NCT04397718 · Phase 2 · Completed
Posted results
- Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients
NCT00245466 · Phase 2 · Terminated
Posted results
- Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix
NCT00434122 · Phase 2 · Completed
Posted results
- Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486
NCT00117949 · Phase 2 · Completed
Posted results
- Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
NCT03689699 · Phase 1/2 · Completed
Posted results
- Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.
NCT03069937 · Phase 2 · Completed
Posted results
- Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
NCT00527488 · Phase 2 · Completed
Posted results
- TRial on the Endocrine Activity of Neoadjuvant Degarelix
NCT02005887 · Phase 2 · Completed
Posted results
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
NCT04126070 · Phase 2 · Active, not recruiting
Posted results
- Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer
NCT00738673 · Phase 2 · Completed
Posted results
- Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients
NCT00117312 · Phase 2 · Terminated
Posted results
- Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
NCT01377389 · Phase 2 · Terminated
Posted results
- A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
NCT01696877 · Phase 1/2 · Completed
Posted results
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT03361735 · Phase 2 · Active, not recruiting
Posted results
- A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy
NCT02849990 · Phase 2 · Completed
Posted results
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
NCT02278185 · Phase 2 · Completed
Posted results
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
NCT02560051 · Phase 2 · Terminated
Posted results
- Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
NCT02494713 · Phase 2 · Terminated
Posted results